Clinical trial
Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen…
NCT00135629 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00135629 |
|---|---|
| Title | Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever |
| Official title | Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: A Pilot Study. (Up-dosing Study) |
| Lead sponsor | Imperial College London, Other |
| Collaborators | ALK-Abelló A/S Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Biological, Other, Procedure |
| Interventions | Active injections of alum-adsorbed grass pollen vaccine (Alutard SQ)., Placebo Injection, Venepuncture: 100ml blood sample taken on 12 separate visits |
| Enrollment | 18 |
| Start date | Oct 1, 2002 |
| Primary completion | Jan 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Aug 26, 2005 |
| Last update posted | May 16, 2024 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: